Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status

March 25, 2013 2:34 pm | by PR Newswire | News | Comments

LOS ANGELES, March 25, 2013 /PRNewswire/ -- OraSure Technologies, Inc. (NASDAQ:OSUR), maker of the OraQuick® In-Home HIV Test, announced today the launch of a nationwide awareness campaign to encourage everyone to learn their HIV status. The campaign, "Make Knowing Your...

FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients

March 22, 2013 7:07 pm | by The Associated Press | News | Comments

GE Healthcare today announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView™ (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.

Lantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses

March 21, 2013 3:30 pm | by The Associated Press | News | Comments

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Mar 21, 2013--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that under its new leadership team led by Jeff Bailey, President and Chief Executive Officer,...

Advertisement

Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer Diagnosis

March 21, 2013 12:45 pm | by The Associated Press | News | Comments

Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world.

WPI and UMass Medical School Team Up to Improve Healthcare Delivery

March 21, 2013 11:22 am | by Worcester Polytechnic Institute | News | Comments

The Healthcare Delivery Institute is a multi-disciplinary organization that includes more than 20 research teams at WPI, external healthcare providers, and industry partners, all working to address the national and global challenge of creating the future of healthcare delivery.

Hologic's 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS

March 19, 2013 5:27 pm | by PR Newswire | News | Comments

BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced...

Douglas Harrington, MD Addresses Select Group of Physicians Regarding Latest Advances in Cardiovascular Risk Assessment

March 19, 2013 2:44 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 19, 2013--Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington, MD, Clinical Professor of Pathology at USC and Aviir, Inc. CEO,...

DiaTech Oncology Test Shows Improved Results, New Hope for Leukemia Patients

March 19, 2013 8:37 am | by The Associated Press | News | Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mar 19, 2013--Results of clinical trials published this month in the medical peer-review journal showed overall survival rate improved 257% for certain groups of leukemia patients when physicians used DiaTech Oncology’s test to help determine chemotherapy...

Advertisement

Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders

March 18, 2013 1:07 pm | by Bio-Medicine.Org | News | Comments

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 Fast DX Real-Time PCR Instruments

March 18, 2013 8:00 am | by The Associated Press | News | Comments

Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from the United States Food and Drug Administration (FDA) to market the Quidel Molecular Direct C. difficile Assay with Life Technologies'...

Pathwork Diagnostics Collaborating with Kindstar Global to Provide Tissue of Origin Test in China

March 14, 2013 11:00 am | by The Associated Press | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 14, 2013--Pathwork Diagnostics, Inc., the innovator of the Pathwork Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, announced today that it has entered into an agreement with Kindstar Global (Kindstar) to provide...

Atossa Genetics Announces National Agreement With Network Provider FedMed

March 13, 2013 8:30 am | by The Associated Press | News | Comments

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S., for diagnostic laboratory testing. FedMed's network is...

NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea

March 12, 2013 7:00 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 12, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement,...

Advertisement

University of Texas Health Science Center at Houston Releases News of Successful NanoLogix Test

March 12, 2013 1:38 am | by The Associated Press | News | Comments

UTHealth researchers say more rapid test for Group B strep successful NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that final results of a 14 month study done by researchers at UTHSC-Houston have been published in a recent online edition of “ Infectious Diseases in Obstetrics and Gynecology.”

Screening for BNP & Targeted Care Reduce Heart Failure in At-Risk Patients

March 11, 2013 5:52 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 11, 2013--Alere Inc. (NYSE: ALR) is pleased to announce the results of research presented at today’s American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be effective in preventing heart...

Designers, Hackers, Healers, & Hustlers Tackle Employee Wellness in Innovation Challenge

March 11, 2013 4:50 pm | by Ryan Wynia, Founder|Design Visioneer, FIREBONE | Articles | Comments

The innovators selected to participate in StartX MedIC were unbelievable individuals. The participants included physicians, surgeons, physicists, electrical engineers, mechanical engineers, computer scientists, data scientists, computer programmers, industrial designers, interface designers, interaction designers, start-up founders, serial entrepreneurs, inventors, PhD students, medical students, and marketing executives from all types organizations and institutions.

Data Presented at ACC 2013 Confirms Use of Corus@ CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions

March 11, 2013 8:31 am | by The Associated Press | News | Comments

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus@ CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...

NovaSom is AASM’s First Approved Out of Center Sleep Test Provider

March 11, 2013 8:04 am | by The Associated Press | News | Comments

GLEN BURNIE, Md.--(BUSINESS WIRE)--Mar 11, 2013--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has been recognized by the American Academy of Sleep Medicine (AASM) as the first Approved Out of Center Sleep...

American Academy of Private Physicians (AAPP) Selects Itamar-Medical’s EndoPAT™ and WatchPAT™ Products to Promote Patient Wellness

March 11, 2013 8:00 am | by The Associated Press | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Mar 11, 2013--Itamar-Medical (TASE: ITMR), the world's leader of noninvasive technology for diagnosis of cardiovascular health, announced today that it has an agreement with the American Academy of Private Physicians (AAPP) to include Itamar's EndoPAT &...

DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test

March 8, 2013 4:37 pm | by Massachusetts Institute of Technology | News | Comments

Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina  to develop early detection tools for autism spectrum disorders, according to a release.

Endeavor Power Corporation Introduces Its Proprietary FDA Cleared Target System Platform Technology

March 8, 2013 8:00 am | by PR Newswire | News | Comments

CAMBRIDGE, Mass., March 8, 2013 /PRNewswire/ -- Endeavor Power Corporation ("Endeavor Power" or the "Company") (OTCQB: EDVP) introduces its proprietary FDA Cleared Target System Platform Immunoassay Testing Technology ("Target System"). Endeavor Sciences, Inc. ("Endeavor"), the...

Philips Healthcare and Infraredx Introduce Solution to Enable Seamless Integration of TVC Imaging System with Philips’ Allura Xper Systems

March 7, 2013 8:30 am | by The Associated Press | News | Comments

ANDOVER, Mass. & BURLINGTON, Mass.--(BUSINESS WIRE)--Mar 7, 2013--Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the availability...

In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization

March 7, 2013 8:04 am | by PR Newswire | News | Comments

Global in vitro diagnostics markets are a bright spot in the healthcare industry largely due to the increasing focus on global expansion. This is particularly seen in emerging markets that continue to gain steam as markets flatten. This briefing, featuring a live Q&A with the industry analyst, will explore the IVD market dynamics in these and other key regions globally.

Clinical Trial Results for Dune Medical Devices' MarginProbe@ System Presented at 66th Annual SSO Cancer Symposium

March 7, 2013 8:01 am | by The Associated Press | News | Comments

Dune Medical Devices, Inc., announced today that results from the pivotal clinical trial for the MarginProbe System, Dune's breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, were presented at the 66th Annual Society of Surgical Oncology (SSO) Cancer ...

HD Medical, Inc. Launches US Business Operations

March 6, 2013 8:05 am | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 6, 2013--At ACC.13, HD Medical Inc. a recently formed medical device research and development innovator headquartered in Santa Clara, CA, today announces the launch of US business operations. This new company is delivering revolutionary diagnostic technologies...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading